Cancer stem cells (CSCs) represent the main target of the current efforts to eradicate cancer, because of their ability to promote metastatic dissemination and survive cytotoxic therapies. Here, we highlight the potential of patient-derived CSCs as an in vitro and in vivo pre-clinical model and of liquid biopsy as a diagnostic, prognostic and predictive tool. We discuss recently developed therapeutic strategies aiming at specifically targeting the cancer stem cell population, particularly focusing on the latest advances in cancer immunotherapy. In fact, it is now widely accepted that the microenvironment plays an active role in supporting tumor progression. Hence, the crosstalk between CSCs and the host immune system is nowadays object of intensive study, with the aim to develop effective therapeutic strategies targeting the ability of CSCs to escape immune-surveillance through immunoediting.

Fiori, M. E., Lidia, V., De Maria Marchiano, R., Cancer stem cells: at the forefront of personalized medicine and immunotherapy, <<CURRENT OPINION IN PHARMACOLOGY>>, 2017; (35): 1-11. [doi:10.1016/j.coph.2017.04.006] [http://hdl.handle.net/10807/111230]

Cancer stem cells: at the forefront of personalized medicine and immunotherapy

Fiori, Micol Eleonora;De Maria Marchiano, Ruggero.
2017

Abstract

Cancer stem cells (CSCs) represent the main target of the current efforts to eradicate cancer, because of their ability to promote metastatic dissemination and survive cytotoxic therapies. Here, we highlight the potential of patient-derived CSCs as an in vitro and in vivo pre-clinical model and of liquid biopsy as a diagnostic, prognostic and predictive tool. We discuss recently developed therapeutic strategies aiming at specifically targeting the cancer stem cell population, particularly focusing on the latest advances in cancer immunotherapy. In fact, it is now widely accepted that the microenvironment plays an active role in supporting tumor progression. Hence, the crosstalk between CSCs and the host immune system is nowadays object of intensive study, with the aim to develop effective therapeutic strategies targeting the ability of CSCs to escape immune-surveillance through immunoediting.
Inglese
Fiori, M. E., Lidia, V., De Maria Marchiano, R., Cancer stem cells: at the forefront of personalized medicine and immunotherapy, <<CURRENT OPINION IN PHARMACOLOGY>>, 2017; (35): 1-11. [doi:10.1016/j.coph.2017.04.006] [http://hdl.handle.net/10807/111230]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/111230
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 34
social impact